Shares of Bioceres Crop Solutions Corp. (NASDAQ:BIOX – Get Free Report) have earned an average rating of “Hold” from the four analysts that are covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, two have given a hold recommendation and one has issued a buy recommendation on the company. The average twelve-month price target among analysts that have issued ratings on the stock in the last year is $4.00.
A number of brokerages have recently commented on BIOX. Wall Street Zen lowered Bioceres Crop Solutions from a “hold” rating to a “sell” rating in a research note on Saturday, April 4th. Weiss Ratings lowered shares of Bioceres Crop Solutions from a “sell (d)” rating to a “sell (d-)” rating in a report on Monday, July 13th.
View Our Latest Stock Analysis on Bioceres Crop Solutions
Bioceres Crop Solutions Price Performance
Bioceres Crop Solutions (NASDAQ:BIOX – Get Free Report) last released its quarterly earnings data on Monday, May 11th. The company reported ($0.16) earnings per share for the quarter, missing the consensus estimate of ($0.05) by ($0.11). Bioceres Crop Solutions had a negative net margin of 92.85% and a negative return on equity of 33.97%. The firm had revenue of $39.40 million for the quarter, compared to analyst estimates of $54.50 million.
Hedge Funds Weigh In On Bioceres Crop Solutions
Several large investors have recently modified their holdings of BIOX. Bank of America Corp DE increased its holdings in Bioceres Crop Solutions by 186.7% in the fourth quarter. Bank of America Corp DE now owns 5,735 shares of the company’s stock valued at $35,000 after purchasing an additional 3,735 shares during the period. Jones Financial Companies Lllp grew its position in shares of Bioceres Crop Solutions by 3,535.8% in the 1st quarter. Jones Financial Companies Lllp now owns 5,490 shares of the company’s stock valued at $25,000 after buying an additional 5,339 shares during the last quarter. PDT Partners LLC grew its position in shares of Bioceres Crop Solutions by 58.9% in the 2nd quarter. PDT Partners LLC now owns 28,180 shares of the company’s stock valued at $126,000 after buying an additional 10,449 shares during the last quarter. Virtu Financial LLC acquired a new stake in shares of Bioceres Crop Solutions in the third quarter valued at about $40,000. Finally, Invesco Ltd. bought a new position in shares of Bioceres Crop Solutions during the fourth quarter worth about $45,000. Institutional investors own 17.68% of the company’s stock.
About Bioceres Crop Solutions
Bioceres Crop Solutions Corp. is an agricultural biotechnology company focused on developing, manufacturing and commercializing a range of crop inputs designed to enhance yields and improve sustainability. The company’s portfolio includes biological seed treatments, inoculants for nitrogen fixation, specialty fertilizers and proprietary biopesticides, which are formulated to support plant health and resilience under varying environmental conditions.
Among its flagship offerings is the HB4 drought-tolerant wheat technology, the first genetically modified wheat developed to withstand water stress, which has received regulatory approval in several markets.
Featured Stories
- Five stocks we like better than Bioceres Crop Solutions
- 2 Unique Space ETFs That Could Upend the Industry
- Corning Stock Crashes on Earnings, But the Sell-Off Looks Overdone
- Palantir’s Earnings Setup Puts Its AI Growth Story Back on Trial Again
- Mining For Megawatts: AMD’s Billion-Dollar Grid Grab
Receive News & Ratings for Bioceres Crop Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioceres Crop Solutions and related companies with MarketBeat.com's FREE daily email newsletter.
